Biomarkers, Risk Factors, and Risk: Clarifying the Controversy About Surrogate End Points and Clinical Outcomes

Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):457-9. doi: 10.1161/CIRCOUTCOMES.115.002245.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers / analysis*
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / therapy
  • Disease Management*
  • Endpoint Determination / methods*
  • Humans
  • Morbidity
  • Risk Assessment*
  • Risk Factors
  • United States / epidemiology

Substances

  • Biomarkers